Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. - Wikidata - awgldk - TriplyDB

Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

http://www.wikidata.org/entity/Q35010060

about

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis Somatic mutagenesis in autoimmunity Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production Sequence-specific binding of normal serum immunoglobulin M to exposed protein C-termini.Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response.B cells: the old new players in reproductive immunology.Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development.CD25 + B-1a Cells Express Aicda.Network theory analysis of antibody-antigen reactivity data: the immune trees at birth and adulthood Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety.The long elusive IgM Fc receptor, FcμR.Pathogenesis of systemic lupus erythematosus (SLE).Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE.Fishing for mammalian paradigms in the teleost immune system.Responsiveness of B cells is regulated by the hinge region of IgD.Ig-binding receptors on human NK cells as effector and regulatory surface molecules.Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.The unexplored roles of human serum IgA.Sca-1 influences the innate immune response during skeletal muscle regeneration.Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease.Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.An apoptosis-associated mammary protein deficiency leads to enhanced production of IgM antibodies against multiple damage-associated molecules.Systemic lupus erythematosus patients contain significantly less igm against mono-methylated lysine than healthy subjects Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques.The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease Many paths lead to lupus.Triggers for anti-chromatin autoantibody production in SLE.Human-derived natural antibodies: biomarkers and potential therapeutics Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction Human B-1 cells take the stage.Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

P2860

Q24672388-F2DE8D26-8EC4-43C3-AFDB-E988DE1B2A35 Q24673242-69F7C376-AB9A-4D13-930F-35CA262C855D Q24805469-031C8C6F-6C76-4B5A-B7A7-ED805F65AC31 Q26745015-D8C54D29-5BA4-454A-B314-F6F1833D11C2 Q26751003-6A287AB3-2CE0-4F83-A688-23903697CE46 Q26860815-49385269-F8B0-4828-82D7-BBC170B02A4B Q27021242-23BABC1A-B5EF-4729-898A-16598EB80C74 Q27024588-248D8776-BBF8-4868-9BA8-DDE4038C9097 Q27026728-08C7DA61-F82B-4444-9C4E-B67E3492ECD9 Q28078102-5A3B9C8F-21DA-4A9A-A59F-AF46D93B7083 Q31061968-EF89E984-F3C4-41C4-A741-EA180BFCF29F Q33752292-404331C5-07B3-4D72-BBD4-FFCC4A3C56A5 Q33789436-CEE00372-1D92-4BC3-8245-83DEFE95C3FB Q33799269-D92F13CE-17BF-4267-A668-98409FB376DE Q33815185-1ACE9215-A8E8-4FA5-AF68-F60BB3C6638F Q33847569-06472EB6-8F8A-4B61-B0A0-71E507DBB3BF Q34056902-78E30D2F-2BAB-42BF-9C51-6EB1A7CCD50D Q34159967-DCFEDD3A-FC92-4A87-8B4C-8869BFF26D19 Q34291300-552A53B1-151A-49F6-AB65-B14D6D6B6095 Q34339372-8F1E905A-F597-4E45-B16C-C000DBF8B9B9 Q34372672-191D4BCA-57E4-49F2-BCB8-87B6799ED8C8 Q34470602-0DEE311C-F572-4863-ACD7-81BBF85851F0 Q34552149-CAE60FD9-7A39-4D5C-9F07-4166C53C4D5C Q34564667-6B039631-D6FF-497F-A1F9-1DC6A8485C53 Q34589997-0AF77A55-7FEC-4E7A-9483-5219B7A5E2A5 Q34597576-92D5FBEB-FCFF-49D0-9E77-32436314ED91 Q34670001-F4EFBA98-8EDD-43AB-AE7C-FAF766E486DB Q34749203-5D84E6FC-F685-4A7A-BF1B-40138C85BB58 Q34816243-2AC2B474-859E-4CDE-8B5C-6EA552BEDD09 Q34848836-50FFB4D0-25F7-4EC7-B098-450C8BC95C7C Q34849082-D892A909-73A9-493E-89B8-CC86320D4AEF Q34881734-0E0C4F72-009C-4299-904D-887677960897 Q34897103-2314AB7B-E91D-4049-A6ED-59A71FE789C0 Q34949611-8CED4598-0FC8-42C5-B443-F976509D8F9A Q35045888-9D91C647-F08F-40CD-88AD-D0256F48F4E8 Q35045914-EFAE65D3-86AA-462E-8118-784B468A6A21 Q35064053-3AA1B83F-5BEA-4929-AEB0-7489A55B4C1F Q35072498-BD80CC53-371D-4929-90A2-249E6E4C5CE5 Q35600416-17C6F286-8228-47A1-82D2-808D35E37E4B Q35609259-0E584ACF-B22C-4718-A2EE-7C05FD39B68E

P2860

Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

http://www.wikidata.org/entity/Q35010060

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Accelerated development of IgG ...... n the absence of secreted IgM.

@ast

Accelerated development of IgG ...... n the absence of secreted IgM.

@en

type

label

Accelerated development of IgG ...... n the absence of secreted IgM.

@ast

Accelerated development of IgG ...... n the absence of secreted IgM.

@en

prefLabel

Accelerated development of IgG ...... n the absence of secreted IgM.

@ast

Accelerated development of IgG ...... n the absence of secreted IgM.

@en

P1433

Q35010060-4D33A83A-B9B1-4318-950E-253A3A848D8D

P1476

Q35010060-C8C7002E-DA45-46CD-B8F5-A48AFFE9953F

P2093

Q35010060-23943DA7-D2E6-4B64-956B-F14440E4074C

Q35010060-24FCF0BC-F81E-49CF-8183-C3D9C849B34F

Q35010060-67D2EDFA-49F0-4953-B6E6-60C8BB5E4A67

Q35010060-77911FB9-220D-409C-BBA9-7CD8EDFD51DC

Q35010060-C28BB7E0-6A25-40C9-9366-CD6B6F5535CC

Q35010060-E062F2AC-8DD6-4C49-A0DD-CC02D4519927

P2860

Q35010060-014D0A37-6A5B-46FB-BD93-89E0D5A31A67

Q35010060-12A06016-7934-433D-8703-7947F6719E0D

Q35010060-1BFC2AC3-F93F-4D3B-9636-1CA1ADF1B2B4

Q35010060-25CF8ECC-95E8-4686-93C2-4EA984430252

Q35010060-2A745B84-59C0-4393-AE25-53D68490CEC2

Q35010060-3966BC5E-530E-4E33-95B4-A6F7D765CD1E

Q35010060-3E9AB39B-9F89-44F7-B2D7-6630DEF741FD

Q35010060-40B6EF6C-D0D0-4027-8DE4-80D942D46FC5

Q35010060-414A1C34-A97B-4B41-862F-4FD82970C5CA

Q35010060-42C9CA63-82BC-4F29-998C-20BA4E21B045

P304

Q35010060-DBB1C11C-C735-43DD-857D-DB566B997304

P31

Q35010060-BF0CF8C9-9F0D-42F5-BBE2-453B2EC90CFD

P356

Q35010060-A299E90C-0DB2-4CAE-858F-A2D787F4BA4D

P407

Q35010060-0254DB40-3E53-4BD2-9A98-7818F4B51834

P433

Q35010060-FD44D5D8-36E1-4863-9EC5-1A4786F3F8A8

P478

Q35010060-9B0D7BFC-0304-4FD4-8F55-9779E707AAD8

P577

Q35010060-6A303871-FCF0-4B83-B389-CF8C51B9EC4F

P5875

Q35010060-26CA4605-9082-4C02-9A69-A3CD144F21B7

P698

Q35010060-C940DDE1-7443-43D8-BD8D-DCC75C7601C3

P921

Q35010060-1D720D1E-7CF0-432F-8CAD-3455B733E445

P932

Q35010060-BAF5B95B-1BF4-49EB-8A2C-607437EC32FC

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Accelerated development of IgG ...... n the absence of secreted IgM.

@en

P2093

A Marshak-Rothstein

http://www.w3.org/2001/XMLSchema#string

B C Beaudette

http://www.w3.org/2001/XMLSchema#string

J Chen

http://www.w3.org/2001/XMLSchema#string

K Linkemann

http://www.w3.org/2001/XMLSchema#string

M Boes

http://www.w3.org/2001/XMLSchema#string

T Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

Complement-dependent clearance of apoptotic cells by human macrophages.

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

Autoimmunity: from physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire.

Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle.

Systemic exposure to irradiated apoptotic cells induces autoantibody production.

P304

1184-1189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.97.3.1184

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235608143

http://www.w3.org/2001/XMLSchema#string

P698

10655505

http://www.w3.org/2001/XMLSchema#string

P921

P932

15562

http://www.w3.org/2001/XMLSchema#string